ISHRS Ms Small Core

Cortez Minerals Expands North American Portfolio, Sets 2026 EBITDA Target and Advances Buyback & Dividend

Akamai Report: Financial Services Face Surge in DDoS Attacks, Banking Accounts for 60%

Akamai Technologies Announces Expansion of Convertible Note Offering to $3 Billion with Pricing

Lumentum Executive VP Vincent Retort Sells 6,482 Shares for Approximately $6.25 Million

Akamai Launches AI Brand Presence Tool, Pilot Shows 85% Citation Increase

ATEME Migrates Dish Home Nepal's Premier League Broadcasts to TITAN Live Platform

MACOM Reports Q2 2026 Earnings, Issues Q3 Guidance Driven by AI Demand

Aixtron Secures Multiple Orders from Lumentum for MOCVD Systems to Meet AI Optical Link Demands

Akamai Plans to Issue $1.3 Billion Convertible Senior Notes Maturing in 2030

MACOM Director Peter Y. Chung Sells 43,268 Shares at $378.2 Per Share

FDA Accepts Viatris Meloxicam NDA, PDUFA Date Set for Dec 2026

Abacus Wealth Increases Stake in Sterling Infrastructure as Earnings Beat Expectations

Revolution Medicines Pancreatic Cancer Drug Trial Shows Positive Results, US Cancer Center Launches Expanded Access Plan Amid Stock Fluctuation

Citigroup Raises Akamai Target Price to $160, Maintains Neutral Rating

Bank of America Raises CF Industries Price Target to $106 as Earnings Beat Expectations

Acme Technology to Acquire Layerx for $205M, Diluting 2026 EPS by $0.12

Zacks Upgrades MACOM Technology Solutions to "Strong Buy", Multiple Brokerages Raise Price Targets

US Clinics Race to Enroll Patients in Revolution Medicines Pancreatic Cancer Drug Early Access Plan After FDA Approval

FactSet Raises Albemarle's 2026 EPS Estimate to $11.56

Bank of America Global Research Upgrades A10 Networks' Rating to Buy and Sets New Price Target

Micware

Silexion Therapeutics

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

GCL Global

Linkage Global

Jupiter Neurosciences

Capstone

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

Arcadia Biosciences

ISCB

SCHA

SCHA and ISCB are both small-cap U.S. equity ETFs with a 0.04% expense ratio. SCHA has a larger asset base ($22 billion) and a higher 1-year return (47.1%) compared to ISCB's $268.5 million and 38.4% return. ISCB offers a slightly higher dividend yield (1.3%) and focuses more on Healthcare and Industrials, while SCHA leans towards Technology. Investors should consider their sector exposure and drawdown tolerance when choosing between the two funds, as both provide diversification in small-cap investments.

nasdaq

Schw Us S-Cp

Charles Schwab

Lumentum

Revolution Medicines

Albemarle

Sandisk

Netflix

NVIDIA

S&P 500

SCHWAB(CHARLES)CORP 5.95% DEP SHS REP 1/40 NON CUM PERP PF D

SCHWAB(CHARLES)CORP 4.450% DEP SHS REP 1/40TH N-CUM PFD SERJ

REVOLUTION MEDICINES INC C/WTS 17/12/2026 (TO PUR COM)

Sandisk - WI

NVIDIA Corporation

SCHA vs. ISCB Comes Down to Sector Tilt and Your Drawdown Tolerance

SPSM

The State Street SPDR Portfolio S&P 600 Small Cap ETF (SPSM) offers a lower expense ratio (0.03%) and a higher dividend yield (1.45%) compared to the iShares Morningstar Small-Cap ETF (ISCB) with an expense ratio of 0.04% and a yield of 1.30%. While ISCB holds more than twice the number of stocks (1,554 vs. 607), both ETFs have similar liquidity and sector weights. Over the past five years, SPSM delivered a total return of 33.07%, slightly outperforming ISCB's 30.04%. Investors may find SPSM more attractive due to its cost efficiency and performance.

SPDR Portfolio S&P 600 Small Cap ETF

Formfactor

Viavi Solutions

Semtech

SPSM Offers Lower Costs and Higher Yield Than ISCB

VTWG

SLYV

The comparison between iShares Trust - iShares Morningstar Small-Cap ETF (ISCB) and State Street SPDR Portfolio S&P 600 Small Cap ETF (SPSM) highlights key differences in expense ratios, dividend yields, and performance. ISCB has a higher expense ratio (0.04%) and lower dividend yield (1.4%) but offers broader diversification and a higher one-year return (23.03%) compared to SPSM's 20.76%. ISCB holds 1,561 companies, while SPSM focuses on 603 stocks from the S&P SmallCap 600 index. Investors should consider their priorities when choosing between these ETFs for small-cap exposure.

ISHRS Ms Small Core(ISCB.US)

SCHA vs. ISCB Comes Down to Sector Tilt and Your Drawdown Tolerance

SPSM Offers Lower Costs and Higher Yield Than ISCB

Small-Cap ETF Investing: ISCB vs. SPSM